Current filters:  
United States
Life Sciences, Biotechnology & Nanotechnology
European Union
WilmerHale
The background on the EC's initial response to the outbreak and its adoption of the Temporary Framework were previously summarized in our prior client alert.
United States
Morrison & Foerster LLP
COVID-19 is, quite literally, putting the medical supply industry to the test. Manufacturers are being pushed to develop novel products like therapies and vaccines
Fenwick & West LLP
The global spread of COVID-19 has impacted all aspects of business and raises significant securities law questions for public life sciences companies.
Arnold & Porter
This quarterly newsletter provides updates on litigation, regulatory, legislative, and other notable developments involving chemicals of concern to business.
Arnold & Porter
The primary legislation governing the authorisation, marketing, sale and supply of pharmaceutical products by the US Food and Drug Administration (FDA)
Arnold & Porter
Despite early high expectations for the role telehealth would play in the US health care delivery system, utilization of telehealth services has--until recently--been relatively modest.
Shipman & Goodwin LLP
We know that right now most providers are in great need of N95 masks and other personal protective equipment ("PPE").
Morrison & Foerster LLP
The rapid spread of coronavirus has spawned prolific marketing claims that any number of products can treat or prevent coronavirus.
Arnold & Porter
In the midst of this coronavirus crisis, many of our friends and colleagues are bravely working in support of the nationwide mobilization now under way.
Reed Smith
We are just going to dive right into it today. Because in a world where the rules and the situation are in such a state of flux and unknown, a little taste of something familiar is reassuring.
Sheppard Mullin Richter & Hampton
The U.S. Food and Drug Administration (FDA) issued two Emergency Use Authorizations (EUA) for commercially distributed COVID-19 diagnostic tests at the end of last week.
Shipman & Goodwin LLP
Here is a current list of "essential services and goods" under Executive Order 7H. We will update as more guidance becomes available:
Duane Morris LLP
As concerns surrounding coronavirus (COVID-19) escalate, U.S. trade policy is aligning with the country's medical needs.
Duane Morris LLP
Noncompete agreements are an effective tool to protect intellectual property in the life sciences industry, but even a well-drafted noncompete agreement may run into challenges when an...
Arnold & Porter
In this chapter, co-authored with Adrian M. Schell, Dr. Freier examines the key legal issues surrounding private equity investments in the biotech/pharma industry.
Duane Morris LLP
FDA announced on March 10, 2020, that the agency is postponing most foreign inspections through April, effective immediately.
Shook, Hardy & Bacon L.L.P.
A data-breach putative class action filed against online retailer Hanna Andersson and Salesforce, its e‑commerce platform, is seemingly the first to cite the California Consumer Protection Act...
Hogan Lovells
Recent data from the U.S. Food and Drug Administration (FDA or the agency) on the percentage of De Novo classification requests that are declined or withdrawn raises...
Worldwide
Arnold & Porter
As COVID-19 spreads across the globe, some of the countries hit hardest by the virus or at grave risk, including Iran and Syria, are subject to the most stringent US economic sanctions.
Hogan Lovells
As the number of cases of COVID-19 (coronavirus) grows in the U.S. and around the world, so too have questions regarding the potential impact of the pandemic on the medical device industry.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Popular Authors
Tools
Font Size:
Translation
Mondaq Social Media